ZYNE stock quote, chart and news. Get Zynerba Pharmaceuticals, Inc.'s stock price today. Stock Market Watch Symbol Lookup Home My Watch View Portfolio Edit. 2019/12/20 · ZYNE - Zynerba Pharmaceuticals Inc. Detailed Chart, Quote and financial news from the leading provider and award-winning. Basic Chart Advanced Chart Home Quotes News Industries Markets Historical Quotes. 2019/12/31 · View today's stock price, news and analysis for Zynerba Pharmaceuticals Inc. ZYNE. Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and more. Tilray’s IPO is creating a buzz, but don’t overspend on marijuana stocks07/08/18Zynerba stock rebounds after selloff driven by failed cannabis-based skin patch trial 06/27. 2019/12/26 · Zynerba Pharmaceuticals, Inc. Common Stock ZYNE Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets. Looking for additional market data? Visit old.
ZYNE - Zynerba Pharmaceuticals Inc. Chart, Quote and financial news from the leading provider and award-winning. OPTION CHAIN FOR ZYNERBA PHARMACEUTICALS INC. 2019/12/18 · ZYNE FINAL DEADLINE: ROSEN LAW FIRM Reminds Zynerba Pharmaceuticals, Inc. Investors of Important Deadline Today in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm. Find real-time ZYNE - Zynerba Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business. Next reporting date March 19, 2020 EPS forecast this quarter-$0.50 Annual revenue last year $86.0K.
Their average twelve-month price target is $21.83, suggesting that the stock has a possible upside of 287.12%. The high price target for ZYNE is $36.00 and the low price target for ZYNE is $11.00. There are currently 1 hold rating. ZYNE Zynerba Pharmaceuticals Inc. NAS 12/4/2019 04:00 PM Last. Check out our ZYNE stock analysis, current ZYNE quote, charts, and historical prices for Zynerba Pharma CS stock. Investors are looking for the stocks that have the potential to lift their portfolios to new heights. These. View breaking news headlines for ZYNE stock from trusted media outlets at MarketBeat. What's going on at Zynerba Pharmaceuticals NASDAQ:ZYNE? View breaking news headlines for ZYNE stock from trusted media outlets.
2019/12/16 · ZYNE By: Douglas W. House, SA News Editor Zynerba Pharmaceuticals ZYNE 21% jumps on more than 50% higher volume in reaction to positive comments from Canaccord Genuity related to Zygel transdermal cannabidiol gel for the potential treatment of developmental and epileptic encephalopathies, a group of rare pediatric epilepsy syndromes including Dravet and Lennox-Gastaut. View Zynerba Pharmaceuticals, Inc. ZYNE investment & stock information. Get the latest Zynerba Pharmaceuticals, Inc. ZYNE detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Within each Score. In depth view into ZYNE Zynerba Pharmaceuticals stock including the latest price, news, dividend history, earnings information and financials. Date Type Description 03/11/2020 Earnings Zynerba Pharmaceuticals Inc Fourth. View the latest ZYNE stock quote and chart on MSN Money. Dive deeper with interactive charts and top stories of ZYNERBA PHARMACEUTICALS, INC. msn back to msn home money powered by Microsoft News web search. View detailed financial information, real-time news, videos, quotes and analysis on Zynerba Pharmaceuticals Inc. NASDAQ:ZYNE. Explore commentary on Zynerba Pharmaceuticals Inc. and hear what the experts at TheStreet are.
Zynerba Pharmaceuticals Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time ZYNE stock price. DOW JONES, A NEWS CORP COMPANY News Corp is a network of leading companies in the. Consensus Rating for ZYNE is STRONG BUY Since many brokers have different rating systems, we maintain a standard system with an assigned numeric value from 1 to 5. Ratings are a translation of brokers' recommendations to. Stock Market Watch Symbol Lookup Home My Watch View Portfolio Edit Portfolio Logout Markets Dow Jones Today S&P Nasdaq NYSE AMEX ETFs World Markets Bonds. 2017/10/05 · Last week, Zynerba released top-line results of their FAB-C study for the treatment of FXS in children. The phase 2 data resulted in ~50% spike in Zynerba Pharm.
Zynerba Pharmaceuticals NASDAQ: ZYNE stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers on Benzinga. MarketWatch Search Symbol Lookup Name Country Security Type BigCharts was unable to find a security, fund or index matching "ZYNEX2019E250000". Company. A stock with a P/E ratio of 20, for example, is said to be trading at 20 times its annual earnings. In general, a lower number or multiple is usually considered better that a higher one. Value investors will typically look for stocks with. MarketWatch Search Symbol Lookup Name Country Security Type BigCharts was unable to find a security, fund or index matching "ZYNEX2019D125000". Company. Earnings Zynerba Pharmaceuticals NASDAQ:ZYNE Earnings Information Zynerba Pharmaceuticals last released its quarterly earnings results on November 6th, 2019. The reported $0.44 earnings per share for the quarter, topping.
Zynerba Pharmaceuticals ZYNE Stock Sinks As Market Gains: What You Should Know by Zacks Equity Research Published on November 04,2019 In the latest trading session, Zynerba Pharmaceuticals ZYNE closed at $7.44, marking a -0.53% move from the previous day.
Cabeau Evolutionクラシックメモリフォームトラベルネックピロー 2021
Harmony Hubリモートバッテリー 2021
Rollie Snow Leopard 2021
6x Battery Mahを称える 2021
オレンジPi 3 Windows 10 2021
3500 Gをkg 2021
HP Deskjet 1000ドライバー 2021
2018 Nhlチャンピオン 2021
Tillakaratne Dilshan Cricbuzz 2021
At＆t 4 Linesは40ドル 2021